Literature DB >> 618628

Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations.

L M Mangiardi, R J Hariman, R G McAllister, V Bhargava, B Surawicz, R Shabetai.   

Abstract

Verapamil was administered intravenously to 30 open-chest dogs and the electrophysiologic and hemodynamic effects of the drug were correlated with the corresponding plasma concentrations. At concentrations below 152 ng/ml, verapamil prolonged the A-H interval, abolished ventriculoatrial conduction, but did not significantly change sinus rate, cardiac output, left ventricular dp/dt, of systemic vascular resistance. Concentrations above 200 ng/ml were associated with slowing of the sinus rat, high degree atrioventricular block during atrial pacing, 24% decrease in mean aortic pressure, and decreased cardiac output and left ventricular dp/dt. Sinus arrest, high degree atrioventicular block during sinus rhythm, decreased systemic vascular resistance and increased left ventricular end-diastolic pressure occurred when plasma verapamil concentrations exceeded 400 ng/ml. These results show that plasma verapamil concentrations reliably reflect the electrophysiologic and hemodynamic actions of the drug, and that "therapeutic" drug effects can be achieved at plasma concentrations at which myocardial depressant effects are unlikely.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 618628     DOI: 10.1161/01.cir.57.2.366

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Neuromuscular blocking action of verapamil in cats.

Authors:  B J Kraynack; N W Lawson; J Gintautas
Journal:  Can Anaesth Soc J       Date:  1983-05

Review 2.  Calcium antagonists. Clinical use in the treatment of systemic hypertension.

Authors:  C Spivack; S Ocken; W H Frishman
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

3.  Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.

Authors:  S W Rabkin; C Tomlinson; B N Corbett; T E Cuddy
Journal:  Can Med Assoc J       Date:  1980-01-12       Impact factor: 8.262

4.  The effects of the novel anti-anginal compound RS 43285 on myocardial conduction in the anaesthetized dog.

Authors:  M C Allely; B J Alps
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

5.  Treatment of verapamil toxicity in intact dogs.

Authors:  R Gay; S Algeo; R Lee; M Olajos; E Morkin; S Goldman
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

Review 6.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

7.  Intrinsic and reflex actions of verapamil and nifedipine: assessment in normal subjects by noninvasive techniques and autonomic blockade.

Authors:  H C Stern; J H Matthews; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Effects of calcium channel blocking and atrial stimulation on QT time during hyper- and normocalcemia in man.

Authors:  C Behrmann; M Runge; J D Ringe
Journal:  Clin Investig       Date:  1992-10

9.  Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat.

Authors:  A M Lefer; E W Polansky; C P Bianchi; S Narayan
Journal:  Basic Res Cardiol       Date:  1979 Sep-Oct       Impact factor: 17.165

Review 10.  Calcium Channel Blockers in Acute Care: The Links and Missing Links Between Hemodynamic Effects and Outcome Evidence.

Authors:  Jin Wang; David L McDonagh; Lingzhong Meng
Journal:  Am J Cardiovasc Drugs       Date:  2021-01       Impact factor: 3.571

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.